Inhalon Biopharma, Inc – Inhalon Biopharma is a startup immunotherapy company developing an inhaled antibody platform for treating a variety of acute respiratory infections. The Company’s intellectual property includes multiple approved U.S. and EU patents broadly covering the composition and use of aerosolized antibodies, licensed from The University of North Carolina at Chapel Hill and Johns Hopkins University.
Location: United States, North Carolina, Chapel Hill
Employees: 1-10
Total raised: $7M
Founded date: 2018
Investors 8
| Date | Name | Website |
| 01.03.2021 | Life Scien... | lifescienc... |
| - | SCP Ventur... | scpventure... |
| - | Exponion | exponion.c... |
| 10.02.2021 | Band of An... | bandangels... |
| - | Flucas Ven... | flucasvc.c... |
| - | K2X | k2x.capita... |
| 22.05.2021 | Berkeley C... | berkeleyca... |
| - | Breakout L... | breakoutla... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.05.2021 | - | $7M | - |
Mentions in press and media 1
| Date | Title | Description |
| 26.05.2021 | Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled "Muco-trapping" Antibody for the Treatment of COVID-19 |